MedPath
NMPA Approval

Recombinant Human Granulocyte Colony-stimulating Factor Injection

国药准字S19980035

November 25, 2020

Drug Information

重组人粒细胞刺激因子注射液

赛格力

赛格力

注射剂

75ug

生物制品

November 25, 2020

Company Information

Applicant Company

Manufacturing Company

中国(上海)自由贸易试验区桂桥路1150号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

重组人粒细胞刺激因子注射液 - NMPA 批准文号 | MedPath